AMES Treatment of the Proximal Arm in Chronic Stroke

Withdrawn before enrolling · Phase 1

Conditions studied: Stroke, Cerebrovascular Accident

In brief

Subjects will receive 30 treatments with AMES, to the proximal arm which has been affected by a chronic stroke.

Key facts

Study ID

NCT01934439

Run by

Oregon Health and Science University

People needed

0

Starts

2013-08-01

Expected to finish

2016-03-01

Last updated by the study team

2019-03-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ischemic or Hemorrhagic stroke affecting the right arm
• One year or longer since stroke
• Severe impairment of right arm with a baseline upper extremity Fugl-Meyer score between 8-24
• Right elbow and shoulder spasticity (Ashworth score ≤3)
• Right shoulder abduction-elbow flexion dyssynergia

You may not qualify if…

• Exercise intolerance
• Co-morbidities limiting arm movement (e.g. shoulder subluxation)
• Chronic pain
• Cognitive dysfunction preventing compliance with instructions
• Participation in other ongoing research studies
• Plans to initiate or discontinue any physical/occupational therapy during the period of enrollment

Where it is running

• Oregon Health and Science University West Campus — Beaverton, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.